SEARCH

SEARCH BY CITATION

References

  • 1
    Wolfe RA, Roys EC, Merion RM. Trends in organ donation and transplantation in the United States, 1999–2008. Am J Transplant 10(4 Pt 2): 961972.
  • 2
    Nelson PW, Delmonico FL, Tolkoff-Rubin NE, et al. Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984; 37: 313314.
  • 3
    Freeman RB, Giatras I, Falagas ME, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999; 68: 11071111.
  • 4
    Lumbreras C, Sanz F, Gonzalez A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 2001; 33: 722726.
  • 5
    Mulvey MR, Chui L, Ismail J, et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001; 39: 34813485.
  • 6
    Garzoni C, Ison MG. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation. Transplantation 92: 12971300.
  • 7
    Grossi PA, Fishman JA. Donor-derived infections in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4): S1926.
  • 8
    Fischer SA, Avery RK. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9(Suppl 4): S718.
  • 9
    Bull DA, Stahl RD, McMahan DL, et al. The high risk heart donor: Potential pitfalls. J Heart Lung Transplant 1995; 14: 424428.
  • 10
    Doig RL, Boyd PJ, Eykyn S. Staphylococcus aureus transmitted in transplanted kidneys. Lancet 1975;2(7928): 243245.
  • 11
    Cerutti E, Stratta C, Romagnoli R, et al. Bacterial- and fungal-positive cultures in organ donors: Clinical impact in liver transplantation. Liver Transpl 2006; 12: 12531259.
  • 12
    Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology 2008; 47: 729736.
  • 13
    Hosein S, Udy AA, Lipman J. Physiological changes in the critically ill patient with sepsis. Curr Pharma Biotech 2011; 12: 19911995.
  • 14
    Christ W. Pharmacological properties of cephalosporins. Infection 1991; 19(Suppl 5): S244252.
  • 15
    Martins N, Martins IS, de Freitas WV, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transplant Infect Dis 2012; 14: 316320.